Location of Repository

Is Post-Marketing Drug Surveillance Possible in the Family Practice Setting? A Collaborative Study

By David P. Facklam, Myrna I. Baker, Jacqueline S. Gardner, Carol Herbert and Inese Grava-Gubins


Post-marketing surveillance is a mechanism to identify and quantify harmful, as well as beneficial, effects of drugs used under conditions different from those in which they were tested. The College of Family Physicians of Canada collaborated with the authors in a pilot, office-based, post-marketing, surveillance study. Target medications were selected from all prescriptions, written or authorized by participating physicians. The participants collected the prescriptions by using duplicate prescription pads. Follow-up data was collected from the patients by means of a self-administered questionnaire and from the physicians by means of a medical-chart review. This method of research allows the identification of a cohort of drug users in a systematic, non-biased fashion

Topics: Research and Education
OAI identifier: oai:pubmedcentral.nih.gov:2218976
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.